AKBA

0.70208.83%

Akebia Therapeutics holds investor meetings at Wells Fargo Healthcare Conference

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Akebia Therapeutics will hold one-on-one investor meetings at the Wells Fargo Healthcare Conference in Boston from September 8-10, 2026. Management plans to discuss commercial products and the clinical-stage kidney disease pipeline.

  • Akebia will hold investor one-on-one meetings at the Wells Fargo Healthcare Conference in Boston on Sept. 8-10, 2026. * Management plans to cover its commercial products, with discussion also expected to include its clinical-stage kidney disease pipeline. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akebia Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609010800PRIMZONEFULLFEED9819085) on September 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

Source: PUBT The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.